表紙:手術用ドレーンの世界市場:タイプ別、製品別、用途別、エンドユーザー別-地域別展望、競合戦略、セグメント予測(~2032年)
市場調査レポート
商品コード
1176947

手術用ドレーンの世界市場:タイプ別、製品別、用途別、エンドユーザー別-地域別展望、競合戦略、セグメント予測(~2032年)

Surgical Drains Market Size- By Type, By Product, By Application, By End User, By End Use- Regional Outlook, Competitive Strategies and Segment Forecasts to 2032

出版日: | 発行: SPER Market Research Pvt. Ltd. | ページ情報: 英文 232 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
手術用ドレーンの世界市場:タイプ別、製品別、用途別、エンドユーザー別-地域別展望、競合戦略、セグメント予測(~2032年)
出版日: 2022年12月14日
発行: SPER Market Research Pvt. Ltd.
ページ情報: 英文 232 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界の手術用ドレーンの市場規模は、2032年まで3.98%で成長し、32億2,000万米ドルに達すると予想されています。創傷や手術部位の感染の増加、外科手術の増加、高齢化、改良型外科・創傷ケア製品の受け入れと認知度向上は、市場の成長を促進しています。

当レポートでは、世界の手術用ドレーン市場について調査分析し、市場力学、市場分析、企業プロファイルなど、体系的な情報を提供しています。

目次

第1章 イントロダクション

  • 調査範囲
  • 市場セグメント分析

第2章 調査手法

  • 調査データソース
    • 二次データ
    • 一次データ
    • SPERの内部データベース
    • KOLの洞察
  • 市場規模の推定
    • トップダウンとボトムアップのアプローチ
  • データの三角測量

第3章 エグゼクティブサマリー

第4章 市場力学

  • 促進要因、抑制要因、機会、課題の分析
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • COVID-19が世界の手術用ドレーン市場に与える影響

第5章 市場変数と展望

  • SWOT分析
    • 強み
    • 弱点
    • 機会
    • 脅威
  • PESTEL分析
    • 政治的情勢
    • 経済的情勢
    • 社会的情勢
    • 技術的情勢
    • 環境的情勢
    • 法的的情勢
  • ポーターのファイブフォース分析
    • 供給企業の交渉力
    • 買い手の交渉力
    • 代替品の脅威
    • 新規参入者の脅威
    • 競争企業間の敵対関係
  • ヒートマップ分析

第6章 世界の手術用ドレーン市場(100万米ドル)(2019年~2032年):タイプ別

  • アクティブドレーン
  • パッシブドレーン

第7章 世界の手術用ドレーン市場(100万米ドル)(2019年~2032年):製品別

  • 付属品
  • 閉鎖型手術用ドレナージシステム
  • 開放型手術用ドレナージシステム
  • 手術用ドレナージシステム

第8章 世界の手術用ドレーン市場(100万米ドル)(2019年~2032年):用途別

  • 一般外科
  • 心臓および胸部外科
  • 整形外科
  • 産婦人科外科

第9章 世界の手術用ドレーン市場(100万米ドル)(2019年~2032年):エンドユーザー別

  • 腹部外科
  • 脳神経外科
  • 胸部および心臓血管外科
  • 整形外科

第10章 世界の手術用ドレーン市場(100万米ドル)(2019年~2032年):最終用途別

  • 外来手術センター
  • 病院

第11章 世界の手術用ドレーン市場(100万米ドル)(2019年~2032年):地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • 中東とアフリカ
    • サウジアラビア王国
    • アラブ首長国連邦
    • その他中東

第12章 企業プロファイル

  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Cardinal Health Inc.
  • ConvaTec Group PLC
  • Cook Medical LLC
  • Degania Silicone Ltd.
  • Ethicon US LLC
  • Global Medikit Ltd.
  • Johnsons and Johnsons
  • Medline Industries Inc.
  • Medtronic PLC
  • Poly Medicure Ltd.
  • Redax S.P.A
  • Romsons Group Private Ltd.
  • Stryker corporation
  • Zimmer Biomet Holdings Inc.
目次
Product Code: MEDE2215

Global Surgical Drains Market Overview:

According to SPER Market Research, the Global Surgery Drains Market is estimated to reach USD 3.22 billion by 2032 with a CAGR of 3.98%.

Implants called surgical drains enable the drainage of liquid and/or gas from a wound or bodily cavity. In the post-operative patient, surgical drains are tubes that are positioned close to surgical wounds to remove pus, blood, or other fluid and stop it from building up in the body. They are continuous drains that keep the gradient of pressure down. By eliminating inflammatory mediators, germs, foreign objects, and necrotic tissue, drains can aid in the healing process. Drains enable monitoring for potential complications by allowing easy fluid sampling during healing; they also enable addressing complications associated with dead space after a pathology report has determined that neoplasia resection is complete, and margins are adequate. Pressure that can impair perfusion as well as cause pain can be relieved by drains, reducing morbidity, and decreasing inflammation. The sort of drainage system that is implanted depends on the patient's demands, the operation, the type of wound, the anticipated volume of drainage, and the surgeon's preference. Surgical drains are made of a number of materials, including latex or plastic, and are used in a broad range of surgical operations, including chest surgery, orthopaedic treatments, and breast surgery (to avoid the gathering of blood and lymph) (the associated risks of raised intrathoracic pressure and tamponade).

Impact of COVID-19 on the Global Surgical Drains Market:

Around the world, nations implemented lockdown and social seclusion, which hindered the development of surgeries. Because fewer procedures are being performed, COVID-19's overall effect on the surgical drainage market is still unfavorable. Surgery necessitates frequent use of reusable tools and close patient interaction. The chance of spreading illness rises as a result. Additionally, government directives to perform operations on patients who need them immediately and postpone them if not, have resulted in a drop in the market for surgical drain goods that are utilized after surgery.

Scope of the Report:

  • Market size available for years: 2019-2032
  • Base year considered: 2021
  • Forecast period: 2022-2032
  • Segments covered: By Type, By Product, By Application, By End User, By End Use
  • Regions covered: North America, Europe, Asia Pacific, Latin America, Middle East and Africa
  • Companies Covered: B. Braun Melsungen AG, Becton, Dickinson and Company, Cardinal Health Inc., ConvaTec Group PLC, Cook Medical LLC, Degania Silicone Ltd., Ethicon US LLC, Global Medikit Ltd., Johnson & Johnsons, Medline Industries Inc., Medtronic PLC, Poly Medicure Ltd., Redax S.P.A, Romsons Group Private Ltd., Stryker Corporation, Zimmer Biomet Holdings Inc.

Global Surgical Drains Market Segmentation:

  • By Type: Based on the Type, Global Surgical Drains Market is segmented as; Active Drain, Passive Drain.
  • By Product: Based on the Product, Global Surgical Drains Market is segmented as; Accessories, Closed Surgical Drainage Systems, Open Surgical Drainage Systems, Surgical Drainage Systems.
  • By Application: Based on the Application, Global Surgical Drains Market is segmented as; General Surgery, Cardiac and Thoracic Surgery, Orthopedic surgery, Obstetric/Gynecological Surgery.
  • By End User: Based on the End User, Global Surgical Drains Market is segmented as; Abdominal Surgery, Neurosurgery, Thoracic and Cardiovascular Surgery, Orthopedics.
  • By End Use: Based on the End Use, Global Surgical Drains Market is segmented as; Ambulatory Surgical Centers, Hospitals.
  • By Region: The market is anticipated to be dominated by North America, then by Europe. Chronic disease is becoming more common. The main drivers propelling the growth of the surgical drains market in North America include wounds and surgical site infections, increasing surgical operations, an ageing population, and more acceptance & awareness of improved surgical & wound care products. The region with the greatest annual average growth rate throughout the predicted period is Asia. Some of the main factors propelling the growth of the surgical drains market in Asia are the high demand for Advanced Wound Care in several Asian countries, rising geriatric population, rising number of surgical procedures, rising prevalence of chronic as well as diabetic wounds, and focus of major players on enhancing their presence in this region.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1 Research data source
    • 2.1.1 Secondary data
    • 2.1.2 Primary data
    • 2.1.3 SPER's internal database
    • 2.1.4 Premium insight from KOL's
  • 2.2 Market size estimation
    • 2.2.1 Top-down and Bottom-up approach
  • 2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1 Drivers
    • 4.1.2 Restraints
    • 4.1.3 Opportunities
    • 4.1.4 Challenges
  • 4.2. COVID-19 Impacts of the Global Surgical Drains Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1 Strengths
    • 5.1.2 Weaknesses
    • 5.1.3 Opportunities
    • 5.1.4 Threats
  • 5.2. PESTEL analysis
    • 5.2.1 Political landscape
    • 5.2.2 Economic landscape
    • 5.2.3 Social landscape
    • 5.2.4 Technological landscape
    • 5.2.5 Environmental landscape
    • 5.2.6 Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1 Bargaining power of suppliers
    • 5.3.2 Bargaining power of Buyers
    • 5.3.3 Threat of Substitute
    • 5.3.4 Threat of new entrant
    • 5.3.5 Competitive rivalry
  • 5.4. Heat map analysis

6. Global Surgical Drains Market, By Type, 2019-2032 (USD Million)

  • 6.1. Active Drain
  • 6.2. Passive Drain

7. Global Surgical Drains Market, By Product, 2019-2032 (USD Million)

  • 7.1. Accessories
  • 7.2. Closed Surgical Drainage Systems
  • 7.3. Open Surgical Drainage Systems
  • 7.4. Surgical Drainage Systems

8. Global Surgical Drains Market, By Application, 2019-2032 (USD Million)

  • 8.1. General Surgery
  • 8.2. Cardiac and Thoracic Surgery
  • 8.3. Orthopedic surgery
  • 8.4. Obstetric/Gynecological Surgery

9. Global Surgical Drains Market, By End User, 2019-2032 (USD Million)

  • 9.1. Abdominal Surgery
  • 9.2. Neurosurgery
  • 9.3. Thoracic and Cardiovascular Surgery
  • 9.4. Orthopedics

10. Global Surgical Drains Market, By End Use, 2019-2032 (USD Million)

  • 10.1 Ambulatory Surgical Centers
  • 10.2 Hospitals

11. Global Surgical Drains Market, By Region, 2019-2032 (USD Million)

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 Germany
    • 11.2.2 United Kingdom
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Rest of Europe
  • 11.3 Asia-Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 Australia
    • 11.3.5 South Korea
    • 11.3.6 Rest of Asia-Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Rest of South America
  • 11.5 Middle East & Africa
    • 11.5.1 Kingdom of Saudi Arabia
    • 11.5.2 United Arab Emirates
    • 11.5.3 Rest of Middle East & Africa

12. Company Profiles

  • 12.1 B. Braun Melsungen AG
    • 12.1.1 Company details
    • 12.1.2 Financial outlook
    • 12.1.3 Product summary
    • 12.1.4 Recent developments
  • 12.2 Becton, Dickinson and Company
    • 12.2.1 Company details
    • 12.2.2 Financial outlook
    • 12.2.3 Product summary
    • 12.2.4 Recent developments
  • 12.3 Cardinal Health Inc.
    • 12.3.1 Company details
    • 12.3.2 Financial outlook
    • 12.3.3 Product summary
    • 12.3.4 Recent developments
  • 12.4 ConvaTec Group PLC
    • 12.4.1 Company details
    • 12.4.2 Financial outlook
    • 12.4.3 Product summary
    • 12.4.4 Recent developments
  • 12.5 Cook Medical LLC
    • 12.5.1 Company details
    • 12.5.2 Financial outlook
    • 12.5.3 Product summary
    • 12.5.4 Recent developments
  • 12.6 Degania Silicone Ltd.
    • 12.6.1 Company details
    • 12.6.2 Financial outlook
    • 12.6.3 Product summary
    • 12.6.4 Recent developments
  • 12.7 Ethicon US LLC
    • 12.7.1 Company details
    • 12.7.2 Financial outlook
    • 12.7.3 Product summary
    • 12.7.4 Recent developments
  • 12.8 Global Medikit Ltd.
    • 12.8.1 Company details
    • 12.8.2 Financial outlook
    • 12.8.3 Product summary
    • 12.8.4 Recent developments
  • 12.9 Johnsons and Johnsons
    • 12.9.1 Company details
    • 12.9.2 Financial outlook
    • 12.9.3 Product summary
    • 12.9.4 Recent developments
  • 12.10 Medline Industries Inc.
    • 12.10.1 Company details
    • 12.10.2 Financial outlook
    • 12.10.3 Product summary
    • 12.10.4 Recent developments
  • 12.11 Medtronic PLC
    • 12.11.1 Company details
    • 12.11.2 Financial outlook
    • 12.11.3 Product summary
    • 12.11.4 Recent developments
  • 12.12 Poly Medicure Ltd.
    • 12.12.1 Company details
    • 12.12.2 Financial outlook
    • 12.12.3 Product summary
    • 12.12.4 Recent developments
  • 12.13 Redax S.P.A
    • 12.13.1 Company details
    • 12.13.2 Financial outlook
    • 12.13.3 Product summary
    • 12.13.4 Recent developments
  • 12.14 Romsons Group Private Ltd.
    • 12.14.1 Company details
    • 12.14.2 Financial outlook
    • 12.14.3 Product summary
    • 12.14.4 Recent developments
  • 12.15 Stryker corporation
    • 12.15.1 Company details
    • 12.15.2 Financial outlook
    • 12.15.3 Product summary
    • 12.15.4 Recent developments
  • 12.16 Zimmer Biomet Holdings Inc.
    • 12.16.1 Company details
    • 12.16.2 Financial outlook
    • 12.16.3 Product summary
    • 12.16.4 Recent developments